Estradiol blood test timing depends on the clinical question your physician plans to answer. Estradiol is the primary circulating estrogen in nonpregnant females of childbearing age. Clinicians designate this molecule E2. When checking ovarian reserve or establishing an in vitro fertilization (IVF) baseline, blood is drawn during the early follicular window on cycle days 2 to 4. For cycle regularity concerns or luteal assessments, blood is drawn during the mid-luteal window.
An undated estradiol test cannot be interpreted accurately. Circulating concentrations shift several-fold across a single menstrual cycle. In an ovulating female, blood levels increase rapidly before declining modestly and rising toward a secondary peak. The official MedlinePlus entry for estrogen testing notes that levels change often and multiple tests help establish a trend. Yet MedlinePlus publishes no numeric reference ranges and does not mention menstrual cycle timing.
The Verdict
Cycle Phase Windows and Published Reference Ranges
Commercial laboratories report estradiol reference ranges by biological cycle phase rather than calendar days. In the United States, Labcorp measures estradiol using the Roche electrochemiluminescence immunoassay (ECLIA) methodology. The laboratory publishes reference intervals across female reproductive life stages. Labcorp publishes no day-numbered bands. Its report groups adult premenopausal values strictly by cycle phase.
According to Labcorp test documentation, the reference range for the follicular phase spans from 12.5 to 166.0 pg/mL. The ovulation phase spans 85.8 to 498.0 pg/mL. During the luteal phase, the published interval sits between 43.8 and 211.0 pg/mL. Postmenopausal reference values range from less than 6.0 to 54.7 pg/mL. Adult male reference intervals span from 7.6 to 42.6 pg/mL. First-trimester pregnancy results range from 215.0 pg/mL to more than 4300.0 pg/mL.
These broad physiological intervals create substantial overlap across different phases. A reading of 100 pg/mL fits inside the follicular phase, the ovulatory window, or the luteal phase. Without an accurate cycle day, that single reading cannot establish your phase. For assay preparation instructions and technical cross-reactivity details, review our separate guide to the estradiol blood test.
| Reproductive Stage or Phase | Reference Range (pg/mL) |
|---|---|
| Follicular phase | 12.5 to 166.0 pg/mL |
| Ovulation phase | 85.8 to 498.0 pg/mL |
| Luteal phase | 43.8 to 211.0 pg/mL |
| Postmenopausal | Less than 6.0 to 54.7 pg/mL |
| Pregnancy (first trimester) | 215.0 to more than 4300.0 pg/mL |
| Adult male | 7.6 to 42.6 pg/mL |
The Bleeding Calendar Versus the Ovulation Clock
A cycle day calculated from bleeding does not align predictably with reference intervals indexed to ovulation. Medical clinics schedule blood tests by counting forward from the onset of menses. Day 1 represents the first day of full bleeding. In contrast, research protocols index biological cycle intervals to the luteinizing hormone surge instead. In those studies, the LH peak is defined as day 0. Days before the surge receive negative numbers. Days after the surge receive positive numbers.
This divergence explains why fixed-day booking causes diagnostic confusion in real-world cycles. In a cycle that is not 28 days, those two clocks do not line up.
Harmonized biological intervals were published in a traceable LC-MS/MS reference-interval study. Researchers measured daily serum samples across full menstrual cycles in 30 healthy premenopausal women using mass spectrometry. The cohort also included 64 men and 33 postmenopausal women, with methods traceable to CDC standards.
Early follicular concentrations from days -15 to -6 spanned 31 to 771 pmol/L. Late follicular levels measured between days -5 and -1 rose sharply, generating an interval of 104 to 1742 pmol/L. Day 0 peaked between 275 and 2864 pmol/L. Early luteal levels from days +1 to +4 dropped to 95 to 1188 pmol/L. Mid-luteal concentrations from days +5 to +9 climbed to a secondary summit, ranging between 151 and 1941 pmol/L. Late luteal readings declined to 39 to 1769 pmol/L. Postmenopausal women in the research cohort showed estradiol concentrations below 26 pmol/L. Healthy men measured 12 to 136 pmol/L. The authors concluded the intervals can be used for medical decision-making with any traceable LC-MS/MS method. The heavy numerical overlap between phases is what makes a single undated draw uninterpretable.
| Cycle Window Relative to LH Peak | Reference Interval (pmol/L) | Equivalent Biological Stage |
|---|---|---|
| Days -15 to -6 | 31 to 771 pmol/L | Early follicular phase |
| Days -5 to -1 | 104 to 1742 pmol/L | Late follicular phase |
| Day 0 (LH peak) | 275 to 2864 pmol/L | LH peak |
| Days +1 to +4 | 95 to 1188 pmol/L | Early luteal phase |
| Days +5 to +9 | 151 to 1941 pmol/L | Mid-luteal phase |
| Days +10 to +14 | 39 to 1769 pmol/L | Late luteal phase |
Cycle Day 2 to 4 Baseline and Reserve Testing
Clinicians draw estradiol between cycle days 2 and 4 when establishing an ovarian-reserve or IVF baseline. Labcorp observes that circulating E2 levels are lowest during the early follicular phase and rise gradually. A draw in that window falls during active bleeding, which is expected rather than a reason to reschedule.
In fertility medicine, doctors traditionally ordered day 3 estradiol to evaluate ovarian reserve. However, the diagnostic standing of this marker has changed over time. Labcorp notes that while early studies suggested E2 levels could predict ovarian reserve in assisted reproduction procedures, more recent studies found the marker less useful.
In premenopausal women, E2 levels, along with luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels, delineate the stage of the menstrual cycle.
Labcorp confirms that E2 is commonly measured for monitoring ovulation induction and during preparation for in vitro fertilization. Because serum E2 concentrations reach relatively high levels in patients undergoing ovarian stimulation, automated immunoassay methods with modest analytical sensitivity meet clinical requirements.
Mid-Cycle Peaks and Luteal Phase Dynamics
Circulating estradiol accelerates rapidly during the final days of follicular maturation to trigger the mid-cycle gonadotropin surge. Labcorp outlines the biological trajectory within an ovulatory cycle. Estradiol levels remain low early and increase gradually throughout follicular development. Two to three days before ovulation, estradiol levels start to increase much more rapidly to a peak just before ovulation. This dramatic increase in circulating E2 levels induces a surge in LH and FSH. Capturing this peak requires precise timing.
Labcorp explains that E2 levels decline modestly during the ovulatory phase before rising again.
Labcorp documents that estradiol levels increase again gradually until the midpoint of the luteal phase, and ultimately decline back to early follicular levels. Mid-luteal testing aims for this summit. Physicians order mid-luteal draws when the question is a cycle problem.
For details on post-ovulatory corpus luteum markers, consult our analysis of progesterone levels by cycle day.
Perimenopausal Disruption of Cycle-Day Patterns
Cycle-day logic degrades during perimenopause. Labcorp highlights that estradiol levels tend to fluctuate dramatically during perimenopause.
There is substantial overlap of the expected range in menopausal women with values observed during normal menstrual cycles. Longitudinal population research clarifies the trajectory of this decline.
Labcorp cites findings from a large population study led by Randolph. The study demonstrated that the mean E2 level started to decline approximately two years prior to the final menstrual period (FMP). Estradiol exhibited a maximal rate of change at the final menstrual period. Mean E2 levels stabilized at a menopausal level approximately two years after the final menstrual period.
Single draws during this transition often mislead. Labcorp notes that measurement of E2 together with FSH and anti-Müllerian hormone (AMH) can be useful in predicting the menopause transition. For multi-marker testing protocols, review the perimenopause biomarker panel and our guide to perimenopause symptoms.
Contraceptive Suppression and Hormone Replacement Therapy
Cycle-day rules do not apply when there is no natural cycle to date the draw against, which is the case on hormonal contraception and on hormone therapy.
Testing estradiol while taking combined hormonal contraceptives produces results that cannot be evaluated against cycle-day norms.
MedlinePlus states that you may need to stop taking certain supplements and medicines before an estrogen test. MedlinePlus specifically instructs patients to tell their provider about everything they take, emphasizing that you should never stop medicines without physician direction.
In postmenopausal females, monitoring requires specialized laboratory assays. Labcorp notes that a sensitive estradiol assay is required to measure E2 levels accurately in postmenopausal women. For postmenopausal monitoring, consult our guides on ultrasensitive estradiol test methodology and evaluating whether your HRT is working.
Laboratory Requisition Details and Test Logistics
Establishing clinical utility from an estradiol test requires recording your cycle day and standardizing laboratory methodology. When booking an estradiol blood draw, communicate the start date of your last menstrual period. The laboratory requisition form should indicate whether the test represents an early follicular baseline, an ovulatory check, or a luteal draw. Without cycle phase context, reference ranges cannot be matched accurately.
Methodological consistency matters when tracking hormonal trends over time. Labcorp explicitly states that estradiol results obtained with different assay methods cannot be used interchangeably in serial testing. To monitor a patient's serial results, it is best to ensure that the same methodology is used each time.
Estradiol does not require overnight fasting. Detailed instructions regarding draw logistics and assay interference factors are detailed in our estradiol blood test guide. Requisition checklist items for booking include:
- Define the clinical question. Specify whether the draw targets ovarian reserve, cycle irregularity, or postmenopausal baseline confirmation.
- Log the cycle day. Record the exact calendar day relative to the onset of full menstrual flow.
- Select the appropriate assay. Use automated immunoassays for assisted reproduction monitoring, but request a sensitive estradiol assay for postmenopausal evaluations.
- Maintain analytical consistency. Ensure the same methodology is used for repeat draws to monitor serial results.
Clinical Indications for Physician Follow-Up
Discordant estradiol levels accompanied by persistent menstrual irregularities warrant direct diagnostic follow-up with a physician. MedlinePlus states that estrogen testing may be needed if you are of childbearing age and have abnormal or absent periods. In females, estrogen testing helps evaluate conditions including early or late puberty, polycystic ovary syndrome (PCOS), and perimenopause.
Unusual hormone pairings require diagnostic workup. Labcorp notes that normal or high E2 with irregular or absent menstrual periods is suggestive of possible polycystic ovarian syndrome. It also suggests possible androgen-producing tumors or estrogen-producing tumors.
Repeated testing often clarifies ambiguous initial values across changing cycle phases. MedlinePlus notes that females may need to be tested more than once to look for a trend over time. For stage criteria and intervention timing, review our guides on the three stages of menopause and when to start HRT. Schedule a comprehensive clinical consultation to evaluate your cycle history alongside an accurate assessment of your estradiol levels by cycle day.
Frequently Asked Questions
What day of my cycle should estradiol be tested?
Estradiol test timing depends on the clinical question your doctor wants to evaluate. For an ovarian reserve evaluation or an in vitro fertilization baseline, blood is drawn during the early follicular phase on cycle day 2, 3, or 4. For cycle concerns, testing occurs mid-luteal or at a symptom-matched point. Testing on an unverified day yields an uninterpretable result because physiological ranges overlap heavily across the cycle.
What is a normal estradiol level on day 3?
A normal day 3 estradiol level falls within the early follicular reference range. Commercial laboratories like Labcorp publish a broad follicular reference interval of 12.5 to 166.0 pg/mL using the Roche ECLIA methodology. In a daily sampling study using traceable mass spectrometry, early follicular levels ranged from 31 to 771 pmol/L. Day 3 testing captures the baseline when E2 levels are lowest. However, Labcorp notes that while early studies suggested estradiol could predict ovarian reserve in assisted reproduction, recent research shows the marker is less useful on its own.
What should estradiol be during the follicular phase?
During the follicular phase, circulating estradiol begins at its lowest baseline and rises gradually. On Labcorp reports using the Roche ECLIA method, the female follicular phase reference interval spans 12.5 to 166.0 pg/mL. In a research study using mass spectrometry traceable to CDC standards, early follicular levels from days -15 to -6 relative to the LH surge ranged from 31 to 771 pmol/L. Late follicular levels from days -5 to -1 rose to 104 to 1742 pmol/L. Concentrations increase gradually in the early follicular window, then accelerate sharply two to three days before ovulation to trigger the mid-cycle luteinizing hormone surge.
What should estradiol be in the luteal phase?
During the luteal phase, estradiol increases to a secondary peak before declining prior to menstruation. Labcorp publishes an adult female luteal phase reference range of 43.8 to 211.0 pg/mL based on the Roche ECLIA assay. In a daily mass spectrometry study indexed to the LH peak as day 0, early luteal levels from days +1 to +4 ranged from 95 to 1188 pmol/L. Mid-luteal levels from days +5 to +9 rose between 151 and 1941 pmol/L. Late luteal concentrations from days +10 to +14 fell to 39 to 1769 pmol/L. E2 levels increase again gradually until the midpoint of the luteal phase and ultimately decline back to early follicular levels.
Can estradiol be tested during your period?
Estradiol is routinely tested during your period when establishing an early follicular baseline. Blood drawn on cycle days 2, 3, or 4 falls directly within active menstrual bleeding. Labcorp reports a broad follicular range of 12.5 to 166.0 pg/mL, with baseline values sitting toward the lower end of that spectrum.
Does the time of day matter for an estradiol test?
The biological cycle phase matters far more than the hour of blood collection. Commercial laboratories like Labcorp publish reference ranges categorized by biological phase rather than morning or afternoon draw times. Furthermore, estradiol testing does not require fasting. The critical requirement is documenting the exact menstrual cycle day and standardizing draw conditions if repeat testing occurs. If you require detailed instructions regarding fasting, sample turnaround times, or assay interference factors, review our dedicated guide to the estradiol blood test.
How does perimenopause change the cycle-day pattern?
Perimenopause disrupts predictable cycle-day patterns through fluctuating hormone production. Labcorp notes that estradiol levels fluctuate dramatically during perimenopause, creating significant numerical overlap between menopausal ranges and normal menstrual values. In a large population study led by Randolph, mean estradiol began to decline approximately two years before the final menstrual period. The maximal rate of change occurred at the final menstrual period, and levels stabilized at postmenopausal ranges roughly two years afterward. Because day-to-day fluctuations are common, measuring estradiol alongside follicle-stimulating hormone and anti-Müllerian hormone helps clinicians assess the menopausal transition.
Can estradiol be tested while on birth control?
Estradiol can be tested while taking birth control, but the result cannot be evaluated against standard cycle-day reference ranges. Cycle-day rules do not apply when there is no natural cycle to date the draw against. MedlinePlus advises that patients may need to stop certain supplements and medicines before testing, but emphasizes that you should never stop any medication unless your healthcare provider specifically instructs you to do so.